Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: Journal of Medical Internet Research

Date Submitted: Aug 11, 2026
Open Peer Review Period: Aug 11, 2026 - Oct 6, 2026
(currently open for review)

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Promoting mental health using a mobile health application in adolescents with a chronic somatic illness: A randomised waitlist controlled trial

  • Marije van Dalen; 
  • Jeroen S. Legerstee; 
  • Hanneke Scholten; 
  • Arend W. van Deutekom; 
  • Sinika Timme; 
  • Suzanne G.M.A. Pasmans; 
  • Loes G.M.T. Keijsers; 
  • Manon H.J. Hillegers

ABSTRACT

Background:

Over 17% of children in the Netherlands live with a chronic illness. They are at risk of developing mental health problems, affecting quality of life and health outcomes.

Objective:

This study evaluates a preventive, transdiagnostic mobile health intervention, the Grow It! app, aiming to enhance overall well being by creating emotional insight and reflection, whilst encouraging the use of adaptive coping strategies.

Methods:

Using a randomised waitlist controlled design, adolescents aged 10–18 years with a chronic somatic illness were recruited through a university medical hospital and randomised to a waitlist control group or an intervention group that used the Grow It! app. Follow up assessments were conducted immediately after the four week intervention period and three months later. After the final follow-up, the waitlist control group also used the Grow It! app and completed questionnaires immediately after and three months later. Primary outcome measures were symptoms of anxiety and depression. Data were analysed with linear mixed models on an intention-to-treat basis.

Results:

Between August 2021 and September 2023, 208 participants were enrolled (Mage=13.96, SD=2.20, 57.69% female), with 105 randomised to the Grow It! intervention group and 103 to the waitlist control group. At the overall group level, symptoms of anxiety (χ2(3, 497.01)=2.08, p=.1021) and depression (χ²(3, 497.01)=0.71, p=.5459) remained stable over time, indicating no significant change across the full sample. However, among adolescents who used the Grow It! app, adolescents with elevated anxiety/depressive at baseline demonstrated the greatest benefit, showing larger symptom reductions than those who initially reported low symptom levels.

Conclusions:

These findings suggest that the Grow It! app may offer meaningful benefits for adolescents with a chronic somatic illness experiencing elevated mood and anxiety symptoms, highlighting its potential value as a preventive and supportive tool in paediatric healthcare. Clinical Trial: International Standard Randomized Controlled Trial Number (ISRCTN) 17883961; https://doi.org/10.1186/ISRCTN17883961


 Citation

Please cite as:

van Dalen M, Legerstee JS, Scholten H, van Deutekom AW, Timme S, Pasmans SG, Keijsers LG, Hillegers MH

Promoting mental health using a mobile health application in adolescents with a chronic somatic illness: A randomised waitlist controlled trial

JMIR Preprints. 11/08/2026:109302

DOI: 10.2196/preprints.109302

URL: https://preprints.jmir.org/preprint/109302

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.